BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure


Creative Commons License

Ozcelik S., Bircan R., Sarikaya S., Gul A. E. , Aydin B., Ozcelik M., ...Daha Fazla

ENDOKRYNOLOGIA POLSKA, cilt.70, ss.401-408, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 70 Konu: 5
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5603/ep.a2019.0025
  • Dergi Adı: ENDOKRYNOLOGIA POLSKA
  • Sayfa Sayıları: ss.401-408

Özet

Introduction: BRAF(V600E) activating mutation is the most frequent genetic abnormality in the pathogenesis of papillary thyroid carcinoma. We aimed to evaluate the association between BRAF(V600E )mutation and well-established prognostic clinicopathological characteristics as well as iodine exposure.